Coronavirus (COVID-19 Spike Protein S1) Antigen, Recombinant >90%

Products_type

Recombinant Protein
Products_short_name

[COVID 19 Spike S1 Coronavirus]
Products_name_syn

[2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spike S1]
Products_gene_name

[COVID-19]
Products_gene_name_syn

[2019-nCoV; SARS-CoV-2; SARS coronavirus 2 proteome; COVID19; SARS-CoV2]
Purity

Affinity Purified Recombinant Antigen (hFc-tag). Purity: >90%
Form

200 mM Phosphate Buffer, pH 7.4
Storage_stability

Short Term: 2-8 degree C. Long Term: -20 degree C. Avoid repeated freezing and thawing.
Tested_application

ELISA (EIA), CLIA, Lateral Flow (LF)
Description

Antigens are peptides or recombinant or native dependent on the production method.
Source

Recombinants or rec. proteins
Group

recombinants

Gene target

Coronavirus COVID-19 Spike Protein >90
Gene symbol

PIRC99, PIRC102, PIRC100, PIRC98, PIRC101
Short name

Coronavirus (COVID-19 Spike Protein S1) Antigen, Recombinant >90%
Technique

Recombinant, antigen, antigenes, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. MyBioSource advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
Host

Mammalian Cell Expression System (HEK293)
Alternative name

Coronavirus (COVID-19 Spike Protein S1) protein, Rec. >90%
Alternative technique

rec, antigenes
Virus

coronavirus

Name

Primary Cell Culture
Concept

Scope note: The initial culturing of cells derived directly from fresh TISSUES.
Tree numbers
- E01.370.225.500.223.500
- E05.200.500.265.500
- E05.242.223.500
- E05.481.500.249.500
Qualifiers

ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data